Stevanato Group S.p.A. (STVN)
- Previous Close
20.91 - Open
21.00 - Bid 20.04 x 900
- Ask 21.13 x 900
- Day's Range
20.21 - 21.14 - 52 Week Range
20.01 - 36.30 - Volume
1,102,133 - Avg. Volume
547,328 - Market Cap (intraday)
5.649B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
35.10 - EPS (TTM)
0.59 - Earnings Date May 9, 2024
- Forward Dividend & Yield 0.06 (0.23%)
- Ex-Dividend Date Jun 7, 2023
- 1y Target Est
29.17
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
www.stevanatogroup.com5,635
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: STVN
Performance Overview: STVN
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STVN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STVN
Valuation Measures
Market Cap
5.65B
Enterprise Value
5.85B
Trailing P/E
37.29
Forward P/E
38.91
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.66
Price/Book (mrq)
3.90
Enterprise Value/Revenue
4.97
Enterprise Value/EBITDA
20.26
Financial Highlights
Profitability and Income Statement
Profit Margin
13.42%
Return on Assets (ttm)
6.72%
Return on Equity (ttm)
13.69%
Revenue (ttm)
1.09B
Net Income Avi to Common (ttm)
145.63M
Diluted EPS (ttm)
0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
72.18M
Total Debt/Equity (mrq)
35.20%
Levered Free Cash Flow (ttm)
-404.78M
Research Analysis: STVN
Company Insights: STVN
STVN does not have Company Insights